Seriniquinones as therapeutic leads for treatment of BRAF and NRAS mutant melanomas (2021)
- Authors:
- USP affiliated authors: MACHADO NETO, JOÃO AGOSTINHO - ICB ; LOTUFO, LETICIA VERAS COSTA - ICB ; HIRATA, AMANDA SOARES - ICB ; TEIXEIRA, PAULA REZENDE - ICB
- Unidade: ICB
- DOI: 10.3390/molecules26237362
- Subjects: FARMACOLOGIA; APOPTOSE; PRODUTOS NATURAIS; PEPTÍDEOS; AMINOÁCIDOS; CÉLULAS CULTIVADAS DE TUMOR; MELANOMA; MOLÉCULA; BACTÉRIAS AERÓBICAS
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Source:
- Este periódico é de acesso aberto
- Este artigo é de acesso aberto
- URL de acesso aberto
- Cor do Acesso Aberto: gold
- Licença: cc-by
-
ABNT
HIRATA, Amanda Soares et al. Seriniquinones as therapeutic leads for treatment of BRAF and NRAS mutant melanomas. Molecules, v. 26, n. 23, p. 1-15, 2021Tradução . . Disponível em: https://doi.org/10.3390/molecules26237362. Acesso em: 27 dez. 2025. -
APA
Hirata, A. S., Teixeira, P. R., Machado Neto, J. A., Jimenez, P. C., Clair, J. J. L., Fenical, W., & Costa-Lotufo, L. V. (2021). Seriniquinones as therapeutic leads for treatment of BRAF and NRAS mutant melanomas. Molecules, 26( 23), 1-15. doi:10.3390/molecules26237362 -
NLM
Hirata AS, Teixeira PR, Machado Neto JA, Jimenez PC, Clair JJL, Fenical W, Costa-Lotufo LV. Seriniquinones as therapeutic leads for treatment of BRAF and NRAS mutant melanomas [Internet]. Molecules. 2021 ; 26( 23): 1-15.[citado 2025 dez. 27 ] Available from: https://doi.org/10.3390/molecules26237362 -
Vancouver
Hirata AS, Teixeira PR, Machado Neto JA, Jimenez PC, Clair JJL, Fenical W, Costa-Lotufo LV. Seriniquinones as therapeutic leads for treatment of BRAF and NRAS mutant melanomas [Internet]. Molecules. 2021 ; 26( 23): 1-15.[citado 2025 dez. 27 ] Available from: https://doi.org/10.3390/molecules26237362 - Seriniquinone, metabolite from a marine bacterium, and its synthetic derivative for melanoma and resistant melanoma cells treatment
- What can we learn from commercial insecticides? Efficacy, toxicity, environmental impacts, and future developments
- Unveiling seriniquinone mechanisms: a promising strategy for treatment of chemoresistant melanoma
- Preclinical development of seriniquinones as selective dermcidin modulators for the treatment of melanoma
- Uncovering metabolic alterations in HCT-116 colon cancer cells upon exposure to bamboo leaf extract obtained from Guadua incana Londoño
- Bismuth(III) triflate: an economical and environmentally friendly catalyst for the Nazarov reaction
- Antitumoral activity of different Amaryllidaceae alkaloids: in vitro and in silico assays
- Metabolomic profiling of Guadua species and its correlation with antioxidant and cytotoxic activities
- AD80, a multikinase inhibitor, as a potential drug candidate for colorectal cancer therapy
- Caracterização do mecanismo de ação da seriniquinona e derivados sintéticos em modelos celulares de melanoma
Informações sobre o DOI: 10.3390/molecules26237362 (Fonte: oaDOI API)
Download do texto completo
| Tipo | Nome | Link | |
|---|---|---|---|
 |
Seriniquinones as Therape... | Direct link |
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
